Clinical

Articles

Application was submitted for both the 81 and 325 mg doses of the liquid-filled capsule formulation of aspirin. 

FDA approves sNDAs for Vazalore

The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction. 

Blockbuster heart drug Entresto gets expanded indication

The recalls of a widely used hypertension blood drug due to carcinogenic impurities are expanding.

Blood pressure drug recalls soar

A pharma maker is voluntarily recalling several lots of a major heart medication. Here’s why.

Popular blood pressure drug recalled

FDA declined to approve Merck’s claim that its cholesterol-lowering drugs Zetia and Vytorin reduce the risk of heart attacks and strokes in patients with coronary heart disease.

FDA denies claims for Zetia, Vytorin

An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug omalizumab (Xolair, Genentech) than in those who were not treated with omalizumab. As a result, FDA has added information about these potential risks to the drug label.

FDA: Slightly elevated risk of cardiovascular, cerebrovascular issues with Xolair

Heart-related hospitalizations, deaths reduced due to coordinated care efforts

Not surprisingly, the treatment costs associated with ACS and its various comorbidities are astoundingly high.

[BLOG] The acute coronary syndrome pipeline: Novel therapies targeting unmet needs in niche patient populations

Unhydrogenated, unsaturated vegetable oils, such as canola oil, can have health advantages when included in as part of a low-glycemic index (GI) diet in people with type 2 diabetes, according to research presented at American Diabetes Association Scientific Sessions in San Francisco, and published in Diabetes Care.

ADA: Canola oil can help control blood glucose in people with type 2 diabetes

FDA has decided not to approve acute heart failure drug serelaxin (Novartis).